Aujeszky’s disease 

This video covers the Aujeszky’s disease in pigs, from the virus characteristics to the dissemination and the routes of infection. Our modified live vaccine is used in controlling and eradication of this swine disease.
AUSKIPRA GN®. Live vaccine, Aujeszky’s disease, gE negative strain, in injectable freeze-dried tablet. COMPOSITION PER DOSE: Live Aujeszky’s disease virus gE negative Bartha K61 strain 105,5 DIC50. INDICATIONS: Swine: To prevent Aujeszky’s disease. ADMINISTRATION ROUTE: Intramuscular, into the neck muscles, or intranasal. For intramuscular administration, either red aqueous solvent (W) or white solvent (A3) can be employed. For intranasal administration, use red aqueous solvent (W), applying 1 ml in each nostril. DOSAGE: Swine: 2 ml/pig, from 10 weeks of age, and second vaccination 3 to 4 weeks later. Revaccinate at least twice during the growth or fattening phase. When animals reach six months of age, they should be vaccinated with a third dose and revaccinated every four months after leaving the farm operation. Future breeders: they should have been vaccinated with a third dose and revaccinated every four months after leaving the farm operation. They should haven been vaccinated at least three times before entering the reproductive cycle. The third dose should be administered when the animals are 21-24 weeks old. In case of an Aujeszky disease outbreak, it is recommended to vaccinate the entire herd (sows, boars and piglets) with one dose. WITHDRAWAL PERIOD: 0 days. OBSERVATIONS: Once reconstituted, administer the vaccine within one hour at most. SPECIAL PRECAUTIONS: Shake gently until complete resuspension of the freeze-dried tablet before administration. Store at +2 to +8 ºC, protected from light. PACKAGING: Pack of 10 vials of 10 ds. Pack of 10 vials of 50 ds. Under veterinary prescription. FOR VETERINARY USE ONLY.